CZ-backed YZi Labs escalates fight over CEA’s ‘poison pill’ and BNB treasury strategy
YZi Labs, backed by CZ, escalates its fight against CEA Industries over governance disputes, including a “poison pill” strategy and BNB treasury management.
YZi Labs, backed by CZ, escalates its fight against CEA Industries over governance disputes, including a “poison pill” strategy and BNB treasury management.
CZ-backed YZi Labs criticizes CEA Industries’ adoption of a poison pill and postponement of its 2025 annual meeting, labeling the actions as “shareholder-unfriendly” amidst escalating boardroom tensions.